SI-BONE Inc. (SIBN) reported fourth‑quarter 2025 revenue of $56.35 million, up 15.0% year‑over‑year and slightly below the revenue estimate of $57.05 million.
Despite top‑line growth, operating and net results weakened materially versus the prior year, with the company reporting wider year‑over‑year declines in profitability measures.
Shares were up 3.03% since market close following the release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
SI-BONE Inc. Insider Trading Activity
SI-BONE Inc. insiders have traded $SIBN stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.
Here’s a breakdown of recent trading of $SIBN stock by insiders over the last 6 months:
- JEFFREY W DUNN has made 0 purchases and 7 sales selling 120,630 shares for an estimated $2,337,969.
- LAURA FRANCIS (Chief Executive Officer) has made 0 purchases and 14 sales selling 115,638 shares for an estimated $1,817,813.
- ANSHUL MAHESHWARI (Chief Financial Officer) has made 0 purchases and 16 sales selling 55,971 shares for an estimated $988,242.
- MICHAEL A. PISETSKY (SVP, Ops & Adm/Chief Legal Ofr) has made 0 purchases and 15 sales selling 50,672 shares for an estimated $891,983.
- ANTHONY J RECUPERO has made 0 purchases and 11 sales selling 31,870 shares for an estimated $510,376.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SI-BONE Inc. Hedge Fund Activity
We have seen 105 institutional investors add shares of SI-BONE Inc. stock to their portfolio, and 88 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST LIGHT ASSET MANAGEMENT, LLC added 3,115,001 shares (+162.4%) to their portfolio in Q4 2025, for an estimated $61,427,819
- ORBIMED ADVISORS LLC removed 2,578,979 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $50,857,465
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 992,762 shares (-47.1%) from their portfolio in Q4 2025, for an estimated $19,577,266
- HOLOCENE ADVISORS, LP removed 585,311 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,615,777
- POINT72 (DIFC) LTD added 581,695 shares (+19887.0%) to their portfolio in Q3 2025, for an estimated $8,562,550
- CADIAN CAPITAL MANAGEMENT, LP added 576,100 shares (+96.8%) to their portfolio in Q4 2025, for an estimated $11,360,692
- AMERICAN CENTURY COMPANIES INC removed 537,599 shares (-18.9%) from their portfolio in Q4 2025, for an estimated $10,601,452
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SI-BONE Inc. Analyst Ratings
Wall Street analysts have issued reports on $SIBN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
- Needham issued a "Buy" rating on 12/16/2025
To track analyst ratings and price targets for SI-BONE Inc., check out Quiver Quantitative's $SIBN forecast page.
SI-BONE Inc. Price Targets
Multiple analysts have issued price targets for $SIBN recently. We have seen 5 analysts offer price targets for $SIBN in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- Mathew Blackman from TD Cowen set a target price of $21.0 on 01/27/2026
- David Rescott from Truist Securities set a target price of $23.0 on 12/18/2025
- Caitlin Roberts from Canaccord Genuity set a target price of $27.0 on 12/17/2025
- David Saxon from Needham set a target price of $27.0 on 12/16/2025
- Drew Ranieri from Morgan Stanley set a target price of $23.0 on 12/02/2025
